Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Former employee appeals verdict from the Patent and Market court of appeal

C-Rad

The Patent and Market Court of Appeal issued a judgment on 30 June 2023 regarding a claim for compensation from a former employee for C-Rad's use of an invention. The Court found that the former employee is only entitled to compensation corresponding to 1/5 of the compensation originally claimed by the former employee. This judgment has now also been appealed by the former employee to the Supreme Court, which must first decide whether to grant leave to appeal.

The background is a lawsuit filed against C-RAD on 9 May 2020 by a former employee claiming compensation for an invention made during his employment at C-RAD. C-RAD strongly rejected the claim for compensation which was considered highly excessive. As previously announced, C-RAD has also appealed the judgement from the Patent and Market Court of Appeal to the Supreme Court.

This is the fourth in a series of disputes where the opposing party was either the same former employee or the company Beamocular AB (owned by the former employee and now in bankruptcy) of which he was the CEO. In all previous cases C-RAD has won.

For further information:


Cecilia de Leeuw, CEO, +46 (0)795 85 66 77, investors@c-rad.com
Christoffer Herou, CFO, +46 (0)725 82 86 16, investors@c-rad.com

About C-RAD


C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

Attachments


Former employee appeals verdict from the Patent and Market court of appeal

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.